ACASTI PHARMA INC's ticker is ACST and the CUSIP is 00430K402. A total of 29 filers reported holding ACASTI PHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $5,000 | – | 15,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 620,000 | $1,519,000 | 0.38% |
| PECONIC PARTNERS LLC | 350,000 | $858,000 | 0.18% |
| Perceptive Advisors | 1,779,882 | $4,361,000 | 0.09% |
| MITCHELL MCLEOD PUGH & WILLIAMS INC | 45,000 | $110,000 | 0.07% |
| Sargent Investment Group, LLC | 125,700 | $308,000 | 0.06% |
| Huber Financial Advisors, LLC | 40,000 | $98,000 | 0.03% |
| Sterling Investment Advisors, Ltd. | 20,000 | $49,000 | 0.02% |
| J. L. Bainbridge & Co., Inc. | 64,125 | $157,000 | 0.02% |
| OXFORD ASSET MANAGEMENT LLP | 275,867 | $676,000 | 0.02% |
| OPPENHEIMER & CO INC | 74,457 | $182,000 | 0.01% |